Scan Monthly No. 011January 2004 |
|
<< Other Issues of Scan Monthly |
Download this Scan™ Monthly (PDF) |
Social-Networking–Software Tools for Business | View summary |
D04-2454 | Download this Insight |
This study examines the rapidly growing field of social-networking software and focuses on the most useful applications for enterprises. Social-networking software builds or finds social networks via Internet connections. One form of social-networking software—it focuses on social-network analysis—appears to have the most immediate potential for businesses. This type of networking software leverages relationship information that already exists within an enterprise, and assembling the network requires no significant time expenditures on the part of employees. Although social-network–analysis applications remain in beta testing and face looming privacy issues, they nevertheless merit attention because of their ability to save companies significant time and effort in finding useful business contacts. Author: Thomas M. McKenna. |
|
Futures Markets as Forecasting Tools | View summary |
D04-2455 | Download this Insight |
Despite the public outcry about the Policy Analysis Market, a U.S. governmentfunded project that aimed to predict terrorist activity, futures markets have become an increasingly popular forecasting tool for businesses and government agencies. Historical data show that commodities futures markets have accurately predicted events that affect these commodities' markets: Orange-juice futures, for example, can predict Florida weather patterns more accurately than meteorologists can. Thus, sources such as the Massachusetts Institute of Technology's Technology Review and Hewlett-Packard want to reap similar benefits by hosting futures markets on ideas and issues important to their businesses. Companies can use futures markets to predict industry trends, forecast sales figures, hedge against harmful macroeconomic conditions, or place bets on future events in the same manner as they would invest money in equities. Though futures markets must stand the test of time to prove their value, they have already caught the attention of some of the world's largest organizations. Author: Greg Powell. |
|
RFID on Top of the Hype Curve | View summary |
D04-2456 | Download this Insight |
In 2003, press reports about RFID (radio-frequency identification) rose to a new level of enthusiasm, maintaining that the technology will revolutionize the supply chain, provide unheard-of efficiency gains, deliver a torrent of useful data, enable completely new applications, and allow consumers to conduct their lives in completely new ways. Although the technology indeed has great potential, these visions are a bit premature. Before RFID can offer the heralded benefits, it must overcome a range of technological, business, and implementation challenges. On the technology front, developers need to improve RFID's reliability and accuracy, reduce interference, develop standards, and put the necessary infrastructure in place. In the market, RFID needs to compete with the existing infrastructure of bar codes and other identification technologies—a challenge the technology cannot meet until costs drop significantly. So far, RFID technology has proved itself in only limited pilot projects or closed settings, such as manufacturing environments. Nonetheless, a number of initiatives—such as Wal-Mart's requirement that its suppliers convert to RFID by 2005—are giving RFID new momentum that could speed its adoption. Author: Martin Schwirn. |
|
Microbioanalytical Devices: Trends and Developments | View summary |
D04-2457 | Download this Insight |
Microarray-based bioanalytical devices have great potential in genomics, proteomics, and metabolomics, offering miniaturized, highly efficient platforms for parallel assays of a large number of biological molecules. These devices are transforming the way that scientists screen drug candidates, identify disease-predisposition markers, and analyze environmental and clinical samples for pathogens or toxic materials. They require 1000 to 10 000 fewer samples per analysis than existing methods do, and they shorten the analysis time from days to minutes—while reducing the cost and increasing the accuracy of analysis. Smaller components, integration of these components, and automation not only save reagents, sample volume, and time but also provide new capabilities. For example, future diagnostic devices will provide rapid analytical results on multiple parameters and enable medical practitioners to diagnose conditions quickly and respond immediately. Given the many benefits of microarray devices, competition to develop the technology is intense. Moreover, several challenges need attention for the devices to gain widespread market acceptance. Most pressing is the need to introduce products at a price the market can afford. Author: Jose Joseph. |